Newborn Infant Parasympathetic Evaluation (NIPE) for Guiding Intraoperative Fentanyl in Children Under 2 Years

Sponsor
Khon Kaen University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05758090
Collaborator
(none)
60
1
2
3.7
16.3

Study Details

Study Description

Brief Summary

During general anesthesia, objective monitoring for analgesia is still lacking. The administration of opioids relies on the experience of the anesthesiologist. There are some monitors, e.g., Analgesia Nociception Index (ANI), showing that they can evaluate analgesia in adults. Recently, a Newborn Infant Parasympathetic Evaluation (NIPE) monitor was released for assessing analgesia in children with age less than 2 years. The investigators aim to assess the efficacy of NIPE as a guide for intraoperative fentanyl administration in children under 2 years.

Condition or Disease Intervention/Treatment Phase
  • Procedure: NIPE monitor
  • Procedure: Control
N/A

Detailed Description

During balanced anesthesia, hypnosis can be monitored with BIS, muscle relaxation can be monitored with a train-of-four, however, analgesia lacks precise monitoring. The anesthesiologist administers narcotics according to clinical signs and experience. Analgesia Nociception Index (ANI) has been introduced as an objective monitor for analgesia in adults. Recently, a Newborn Infant Parasympathetic Evaluation (NIPE) monitor has been introduced to assess analgesia in children under 2 years, however, clinical studies regarding its clinical efficacy are scarce.

The objective of this study is to assess the efficacy of NIPE as a guide for intraoperative fentanyl administration in children under 2 years.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Newborn Infant Parasympathetic Evaluation (NIPE) Index Versus Standard Hemodynamic Response for Guiding Intraoperative Fentanyl Administration in Children Younger Than 2 Years Under General Anesthesia
Anticipated Study Start Date :
Mar 10, 2023
Anticipated Primary Completion Date :
May 31, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group NIPE

Intraoperative fentanyl administration will be guided by NIPE protocol

Procedure: NIPE monitor
Procedure/Surgery: NIPE protocol. Give intraoperative fentanyl according to NIPE value. NIPE score 50-70 indicates optimal narcotic effect. NIPE score > 70 indicated overdosage of narcotic and narcotic should be withheld. NIPE score < 50 indicates inadequate narcotic and narcotic should be given.

Placebo Comparator: Group Control

Intraoperative fentanyl administration will be guided by clinical signs

Procedure: Control
Procedure/Surgery: Standard protocol. Give intraoperative fentanyl according to vital signs.

Outcome Measures

Primary Outcome Measures

  1. Postoperative pain: Face, Legs, Activity, Cry, Consolability scale (FLACC scale) [During 120 minutes in PACU]

    Assess pain using a FLACC score every 15 minutes. FLACC has a range from 0 to 10 with 0 indicates no pain while 10 indicates worst pain. NRS of 0-3 is mild, 4-6 is moderate, and 7-10 is severe pain.

Secondary Outcome Measures

  1. Postoperative fentanyl consumption [During 120 minutes in PACU]

    Fentanyl administration in PACU

  2. Postoperative sedation score [During 120 minutes in PACU]

    Sedation score (0-3; higher scores mean a worse outcome) in PACU

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 2 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Newborn up to 2 years old

  • ASA Status 1-2

  • Undergoing elective surgery of upper part of body

Exclusion Criteria:
  • Premature

  • Arrhythmia

  • Concomitant use of regional anesthesia

  • Plan for ICU admission

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Medicine, Khon Kaen University Khon Kaen Thailand 40002

Sponsors and Collaborators

  • Khon Kaen University

Investigators

  • Study Chair: Sirirat Tribuddharat, MD, PhD, Khon Kaen University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thepakorn Sathitkarnmanee, Associate Professor, Khon Kaen University
ClinicalTrials.gov Identifier:
NCT05758090
Other Study ID Numbers:
  • HE651243
First Posted:
Mar 7, 2023
Last Update Posted:
Mar 7, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 7, 2023